Search

everythinglearnresearchcommunity

for

Search:↓

Atrazine and finasteride disrupt hormone signaling and affect frog development.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

5α-reductase enzymes are crucial in certain disorders, and while treatment advances exist, more research on SRD5A3 is needed.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

Steroid 5α-reductase evolved from protists and diversified in eukaryotes, with specific roles in mammals and plants.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

All five human steroid 5α-reductase enzymes are found in the endoplasmic reticulum.

5α-reductase enzyme affects hormone levels, influencing conditions like acne and hair loss.

New SRD5A2 variants may disrupt protein function, aiding diagnosis and treatment of related disorders.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

A rare gene variant causes sexual development issues in siblings, needing personalized treatment.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

SRD5A2 gene variations affect PTSD symptoms differently in males and females.

5α-reductases increase epitestosterone's effect on androgen receptors.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

The research helps understand how finasteride works and aids drug development.

SRD5A2 enzyme expression varies in benign prostates and can be influenced by inflammation, affecting treatment options.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Four-amino acid part makes enzyme sensitive to finasteride.

No link found between specific genes and female pattern hair loss.

Environmental factors affect reproductive traits by altering the SRD5A1 gene.